Monthly Archives: July 2023

Introduction…. ”Suicide is the tenth leading cause of death in North America, and the leading cause in those aged 15–24 years worldwide [1]. For every adult who dies by suicide, more than 20 others attempt it [2]. Among the modifiable … Continue reading

Posted in Uncategorized | Comments Off on Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study

https://www.nature.com/articles/s41586-023-06331-x

Posted in Uncategorized | Comments Off on Asymptomatic SARS-CoV-2 Infection

Infections can lead to persistent or long-term symptoms and diseases such as shingles after varicella zoster, cancers after human papillomavirus, or rheumatic fever after streptococcal infections(1,2). Similarly, infection by SARS-CoV-2 can result in Long COVID, a condition characterized by symptoms … Continue reading

Posted in Uncategorized | Comments Off on Genome-wide Association Study of Long COVID

Multiple sclerosis is characterised by the chronic inflammatory destruction of myelinated axons in the central nervous system. Several ideas have been put foward to clarify the roles of the peripheral immune system and neurodegenerative events in such destruction. Yet, none … Continue reading

Posted in Uncategorized | Comments Off on The pathogenesis of multiple sclerosis: a series of unfortunate events

Abstract: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in a serious public health burden worldwide. In addition to respiratory, heart, and gastrointestinal symptoms, patients infected with SARS-CoV-2 experience a … Continue reading

Posted in Uncategorized | Comments Off on Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein-Barr virus and the gut-brain axis

https://kpe.utoronto.ca/faculty-news/kpe-says-goodbye-roy-shephard-world-renowned-authority-field-physical-activity-and https://doi.org/10.14288/hfjc.v4i3.118

Posted in Uncategorized | Comments Off on Roy Shephard, world-renowned authority in the field of physical activity and health

Abstract Introduction: Major depressive disorder (MDD) is associated with low-grade inflammation, and anti-inflammatory treatment can help improve depressive symptoms. A recent study found that fluvoxamine (FLV) can reduce Interleukin-6 (IL-6) production via sigma-1 receptor in inflammation models. However, the anti- … Continue reading

Posted in Uncategorized | Comments Off on Effect of fluvoxamine on plasma interleukin-6 in patients with major depressive disorder: a prospective follow-up study